The global leader's innovative regenerative medical technology and devices vastly improve patient outcomes and reduce overall medical costs. SINGAPORE, Nov. 8, 2022 /PRNewswire/ Osteopore International (ASX:OSX) ("Osteopore", "OSX" or the "Company"), a Singapore- and Australia-based med-tech company focusing on facilitating natural tissue regeneration, is primed for the global limelight after quietly developing and commercialising its novel 3D-printed bioresorbable scaffold implants that have the potential to revolutionise the way surgeons help patients to naturally regrow bones and other tissues. Left to Right: Mark Leong, Executive Chairman of Osteopore, Goh Khoon Seng, CEO of Osteopore and Lim Jing, COO & CTO of Osteopore Osteopore leverages technology that has been researched and developed in Singapore and its patent-protected 3D-printed scaffold implants use a bioresorbable material to mimic the complex and inter-connected microstructure of b
Image: lenets tan/Adobe Stock In collaboration with Maastricht University Medical Centre in the Netherlands, Singapore’s Osteopore has developed a PCL-based cage that stimulates regrowth of bone cells and is eventually replaced by the regenerated bone tissue.
Singapore-based Osteopore International has developed in collaboration with Maastricht University Medical Centre (UMC+) in the Netherlands a bioresorbable 3D-printed cage that prevents leg amputations in patients with severe lower leg fractures. The 3D-printed cage helps a patient regenerate new bone cells and has been successfully designed and implanted in its first patient in the Netherlands.
Manufactured in Singapore, and developed with Osteopore s proprietary 3D-printing and materials technology, the cage is made of biodegradable material and is customized based on a computed tomography (CT) scan of the patient s lower leg. This 3D-printed cage stimulates the patient s new bone cells to g
Singapore develops bioresorbable bone implant solution to prevent leg amputations
Singapore develops bioresorbable bone implant solution to prevent leg amputations 29 January 2021 | News Osteopore and National Additive Manufacturing Innovation Cluster have formed a partnership to upscale clinical adoption in Additive Manufacturing
Source: osteopore.com
Osteopore International, a Singapore based company that specialises in 3D printed bioresorbable implants, in collaboration with Maastricht University Medical Centre (UMC+) in the Netherlands, has successfully developed a bioresorbable 3D printed cage that prevents leg amputations in patients with severe lower leg fractures. The 3D printed cage helps a patient regenerate new bone cells and has been successfully designed and implanted in its first patient in the Netherlands.